{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:36:45Z","timestamp":1789774605406,"version":"4.0.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Distinguished Taishan Scholars in Climbing Plan","award":["tspd20210321"],"award-info":[{"award-number":["tspd20210321"]}]},{"name":"the Distinguished Taishan Scholars in Climbing Plan","award":["tspd20210321"],"award-info":[{"award-number":["tspd20210321"]}]},{"name":"the Distinguished Taishan Scholars in Climbing Plan","award":["tspd20210321"],"award-info":[{"award-number":["tspd20210321"]}]},{"name":"the Distinguished Taishan Scholars in Climbing Plan","award":["tspd20210321"],"award-info":[{"award-number":["tspd20210321"]}]},{"name":"the Distinguished Taishan Scholars in Climbing Plan","award":["tspd20210321"],"award-info":[{"award-number":["tspd20210321"]}]},{"name":"the Distinguished Taishan Scholars Plan","award":["tstp20230653"],"award-info":[{"award-number":["tstp20230653"]}]},{"name":"the Distinguished Taishan Scholars Plan","award":["tstp20230653"],"award-info":[{"award-number":["tstp20230653"]}]},{"name":"the Distinguished Taishan Scholars Plan","award":["tstp20230653"],"award-info":[{"award-number":["tstp20230653"]}]},{"name":"the Distinguished Taishan Scholars Plan","award":["tstp20230653"],"award-info":[{"award-number":["tstp20230653"]}]},{"name":"the Distinguished Taishan Scholars Plan","award":["tstp20230653"],"award-info":[{"award-number":["tstp20230653"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82070160, 82370165"],"award-info":[{"award-number":["82070160, 82370165"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82070160, 82370165"],"award-info":[{"award-number":["82070160, 82370165"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82070160, 82370165"],"award-info":[{"award-number":["82070160, 82370165"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82070160, 82370165"],"award-info":[{"award-number":["82070160, 82370165"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82070160, 82370165"],"award-info":[{"award-number":["82070160, 82370165"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["2022JC012"],"award-info":[{"award-number":["2022JC012"]}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["2022JC012"],"award-info":[{"award-number":["2022JC012"]}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["2022JC012"],"award-info":[{"award-number":["2022JC012"]}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["2022JC012"],"award-info":[{"award-number":["2022JC012"]}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["2022JC012"],"award-info":[{"award-number":["2022JC012"]}]},{"name":"the Independently Cultivate Innovative Teams of Jinan, Shandong Province","award":["2021GXRC050"],"award-info":[{"award-number":["2021GXRC050"]}]},{"name":"the Independently Cultivate Innovative Teams of Jinan, Shandong Province","award":["2021GXRC050"],"award-info":[{"award-number":["2021GXRC050"]}]},{"name":"the Independently Cultivate Innovative Teams of Jinan, Shandong Province","award":["2021GXRC050"],"award-info":[{"award-number":["2021GXRC050"]}]},{"name":"the Independently Cultivate Innovative Teams of Jinan, Shandong Province","award":["2021GXRC050"],"award-info":[{"award-number":["2021GXRC050"]}]},{"name":"the Independently Cultivate Innovative Teams of Jinan, Shandong Province","award":["2021GXRC050"],"award-info":[{"award-number":["2021GXRC050"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00277-025-06495-8","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:07:20Z","timestamp":1751933240000},"page":"3703-3711","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy and safety analysis of different treatment regimens in newly diagnosed acute promyelocytic leukemia"],"prefix":"10.1007","volume":"104","author":[{"given":"Di","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"issue":"15","key":"6495_CR1","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1182\/blood-2019-01-894980","volume":"133","author":"MA Sanz","year":"2019","unstructured":"Sanz MA, Fenaux P, Tallman MS et al (2019) Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet. Blood 133(15):1630\u20131643","journal-title":"Blood"},{"issue":"20","key":"6495_CR2","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.1182\/blood-2010-01-264432","volume":"116","author":"Y Yamamoto","year":"2010","unstructured":"Yamamoto Y, Tsuzuki S, Tsuzuki M et al (2010) BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia. Blood 116(20):4274\u20134283","journal-title":"Blood"},{"issue":"1","key":"6495_CR3","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1182\/hematology.2023000477","volume":"2023","author":"O Odetola","year":"2023","unstructured":"Odetola O, Tallman MS (2023) How to avoid early mortality in acute promyelocytic leukemia. Hematol Am Soc Hematol Educ Program 2023(1):248\u2013253","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"5","key":"6495_CR4","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/bjh.14974","volume":"179","author":"D Cholujova","year":"2017","unstructured":"Cholujova D, Bujnakova Z, Dutkova E et al (2017) Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myeloma. Br J Haematol 179(5):756\u2013771","journal-title":"Br J Haematol"},{"issue":"2","key":"6495_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/17474086.2019.1562332","volume":"12","author":"M Breccia","year":"2019","unstructured":"Breccia M, Fo\u00e0 R (2019) Intravenous arsenic trioxide and all-trans retinoic acid as front-line therapy for low-risk acute promyelocytic leukemia. Expert Rev Hematol 12(2):81\u201387","journal-title":"Expert Rev Hematol"},{"issue":"3","key":"6495_CR6","first-page":"83","volume":"102","author":"E Sabattini","year":"2010","unstructured":"Sabattini E, Bacci F, Sagramoso C et al (2010) WHO classification of tumours of Haematopoietic and lymphoid tissues in 2008: an overview. Pathologica 102(3):83\u201387","journal-title":"Pathologica"},{"issue":"6","key":"6495_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41408-021-00514-3","volume":"11","author":"M Yilmaz","year":"2021","unstructured":"Yilmaz M, Kantarjian H, Ravandi F (2021) Acute promyelocytic leukemia current treatment algorithms. Blood Cancer J 11(6):123","journal-title":"Blood Cancer J"},{"issue":"16","key":"6495_CR8","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1200\/JCO.2004.99.116","volume":"22","author":"U Creutzig","year":"2004","unstructured":"Creutzig U, Kaspers GJ (2004) Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol 22(16):3432\u20133433","journal-title":"J Clin Oncol"},{"issue":"4","key":"6495_CR9","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1182\/blood-2008-07-168617","volume":"113","author":"P Montesinos","year":"2009","unstructured":"Montesinos P, Bergua JM, Vellenga E et al (2009) Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors. Blood 113(4):775\u2013783","journal-title":"Blood"},{"issue":"2","key":"6495_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1300874","volume":"369","author":"F Lo-Coco","year":"2013","unstructured":"Lo-Coco F, Avvisati G, Vignetti M et al (2013) Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med 369(2):111\u2013121","journal-title":"N Engl J Med"},{"issue":"13","key":"6495_CR11","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/S1470-2045(15)00193-X","volume":"16","author":"AK Burnett","year":"2015","unstructured":"Burnett AK, Russell NH, Hills RK et al (2015) Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial. Lancet Oncol 16(13):1295\u20131305","journal-title":"Lancet Oncol"},{"issue":"6","key":"6495_CR12","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1200\/JCO.2016.67.1982","volume":"35","author":"U Platzbecker","year":"2017","unstructured":"Platzbecker U, Avvisati G, Cicconi L et al (2017) Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in Non-High-Risk acute promyelocytic leukemia: final results of the randomized Italian-German APL0406 trial. J Clin Oncol 35(6):605\u2013612","journal-title":"J Clin Oncol"},{"issue":"2","key":"6495_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/bjh.16151","volume":"187","author":"M Stahl","year":"2019","unstructured":"Stahl M, Tallman MS (2019) Differentiation syndrome in acute promyelocytic leukaemia. Br J Haematol 187(2):157\u2013162","journal-title":"Br J Haematol"},{"key":"6495_CR14","doi-asserted-by":"publisher","first-page":"1062524","DOI":"10.3389\/fonc.2022.1062524","volume":"12","author":"SG Iyer","year":"2022","unstructured":"Iyer SG, Elias L, Stanchina M et al (2022) The treatment of acute promyelocytic leukemia in 2023: paradigm, advances, and future directions. Front Oncol 12:1062524","journal-title":"Front Oncol"},{"issue":"Suppl 1","key":"6495_CR15","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1016\/S0049-3848(20)30399-6","volume":"191","author":"MA Sanz","year":"2020","unstructured":"Sanz MA, Montesinos P (2020) Advances in the management of coagulopathy in acute promyelocytic leukemia. Thromb Res 191(Suppl 1):S63\u2013s7","journal-title":"Thromb Res"},{"key":"6495_CR16","doi-asserted-by":"publisher","first-page":"102351","DOI":"10.1016\/j.bcmd.2019.102351","volume":"79","author":"W Hou","year":"2019","unstructured":"Hou W, Zhang Y, Jin B et al (2019) Factors affecting thrombohemorrhagic early death in patients with acute promyelocytic leukemia treated with arsenic trioxide alone. Blood Cells Mol Dis 79:102351","journal-title":"Blood Cells Mol Dis"},{"issue":"5","key":"6495_CR17","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/sj.leu.2401755","volume":"14","author":"M Ohsawa","year":"2000","unstructured":"Ohsawa M, Koyama T, Shibakura M et al (2000) Arsenic trioxide (As2O3) gradually downregulates tissue factor expression without affecting thrombomodulin expression in acute promyelocytic leukemia cells. Leukemia 14(5):941\u2013943","journal-title":"Leukemia"},{"key":"6495_CR18","doi-asserted-by":"publisher","first-page":"112167","DOI":"10.1016\/j.biopha.2021.112167","volume":"143","author":"M Zhang","year":"2021","unstructured":"Zhang M, Xue Y, Zheng B et al (2021) Liquiritigenin protects against arsenic trioxide-induced liver injury by inhibiting oxidative stress and enhancing mTOR-mediated autophagy. Biomed Pharmacother 143:112167","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"6495_CR19","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1182\/blood-2007-07-100669","volume":"111","author":"J De la Serna","year":"2008","unstructured":"De la Serna J, Montesinos P, Vellenga E et al (2008) Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and Idarubicin. Blood 111(7):3395\u20133402","journal-title":"Blood"},{"issue":"4","key":"6495_CR20","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1182\/blood.V82.4.1264.1264","volume":"82","author":"W Huang","year":"1993","unstructured":"Huang W, Sun GL, Li XS et al (1993) Acute promyelocytic leukemia: clinical relevance of two major PML-RAR alpha isoforms and detection of minimal residual disease by retrotranscriptase\/polymerase chain reaction to predict relapse. Blood 82(4):1264\u20131269","journal-title":"Blood"},{"issue":"1","key":"6495_CR21","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s12011-023-03676-2","volume":"202","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Zhang S, Zhang F et al (2024) Clinical indicators of hepatotoxicity in newly diagnosed acute promyelocytic leukemia patients undergoing arsenic trioxide treatment. Biol Trace Elem Res 202(1):122\u2013132","journal-title":"Biol Trace Elem Res"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06495-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06495-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06495-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T01:23:08Z","timestamp":1757208188000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06495-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["6495"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06495-8","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The retrospective, observational study was approved by the Ethics Committee of Qilu Hospital, Shandong University, and was conducted in accordance with the Declaration of Helsinki. All authors of this article agree to publish in your journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"After fully understanding the research content, all participants voluntarily signed the written informed consent form, indicating their agreement to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The Ethics Committee of Qilu Hospital approved waiving the need to obtain written informed consent from each participant.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}